Latest News, Press Releases & Events

Spyryx Biosciences Partners with Cystic Fibrosis Canada, Serves as Presenting Sponsor of the 16th Broken Arrow Conference May 4-6, Toronto, Ontario

Company continues its outreach to the CF community in support of SPX-101’s Phase 2 clinical program DURHAM, N.C., May 4, 2017 – Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung disease, announced today that it will serve as the presenting sponsor of Cystic Fibrosis Canada’s 16th Broken Arrow Conference. […]

Continue Reading

Spyryx Biosciences to Present at the Needham Healthcare Conference

Spyryx Biosciences to Present at the Needham Healthcare Conference Tuesday, April 4, 2017 New York, NY Durham, North Carolina – March 29, 2017. Spyryx Biosciences, a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, announced today that John Taylor, President and CEO, will present at the Needham Healthcare Conference on Tuesday, April […]

Continue Reading

Spyryx Biosciences Marks Rare Disease Day With an Update on Clinical Trials for SPX-101

Spyryx Biosciences Marks Rare Disease Day With an Update on Clinical Trials for SPX-101 DURHAM, N.C., February 28, 2017 – Spyryx Biosciences, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today announced the details of an upcoming Phase 1b study to evaluate the safety of SPX-101 in patients with […]

Continue Reading